Effect of rapamycin on islet and skin xenograft survival.
Bobbio
S A
SA
Division of Organ Transplantation, New England Deaconess Hospital, Harvard Medical School, Boston, Massachusetts 02215.
Porter
J G
JG
Monaco
A P
AP
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000276:immunology*; D003921:Diabetes Mellitus, Experimental / Q000601:surgery; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016381:Islets of Langerhans Transplantation / Q000276:immunology*; D051379:Mice; D008815:Mice, Inbred Strains; D011090:Polyenes / Q000627:therapeutic use*; D051381:Rats; D011920:Rats, Inbred WF; D020123:Sirolimus; D016038:Skin Transplantation / Q000276:immunology*; D013997:Time Factors; D014183:Transplantation, Heterologous / Q000276:immunology*
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D011090:Polyenes; D020123:Sirolimus